EUCTR2007-002649-19-EE进行中（未招募）不适用
Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder
Tartu University Hospital Psychiatry Clinic0 个研究点目标入组 500 人开始时间: 2009年12月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To participate in the study, the subjects must be at least 18 years old and give a written informed consent after an oral and written explanation of the study aims and methods. The study sample will include at least 150 female and 150 male patients with PD diagnosis according to DSM-IV criteria with or without comorbid depression. The additional inclusion criteria will be at least moderate clinical severity, suitability to treatment with an SSRI
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •history of other psychiatric disorders, such as organic mental disorders, substance use disorders, psychotic disorders, bipolar disorder; serious somatic diseases; pregnancy
研究者
相似试验
已完成
4 期
Investigation of Genetic Predictors of the Response to Selective Serotonin Re-Uptake Inhibitors TreatmentAntidepressantTreatment predictionMental Health - DepressionDepressionACTRN12609000295246Tartu University135
尚未招募
Unknown
Genetics of margin-negative Oral Squamous Cell Carcinoma surgical resection.CTRI/2023/11/060253ICMR
招募中
不适用
Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p/19q, and mutation of IDH1/2.GliomaJPRN-UMIN000003196Yokohama City University of Medicine100
已完成
不适用
Analysis of genetic polymorphisms for predicting response to treatment and progression of prostate tumorProstate cancerJPRN-UMIN000009785Department of Urology, Akita University Graduate School of Medicine200
已完成
不适用
Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents.Non-small-cell lung cancer1002765610029107lung cancerNL-OMON47255Sint Antonius Ziekenhuis350